首页 | 本学科首页   官方微博 | 高级检索  
     

低分子肝素与分次给予普通肝素治疗进展型脑梗死临床疗效对比
引用本文:代瑞廷,曹艳霞,李晓芳,王淑仙,苏立凯. 低分子肝素与分次给予普通肝素治疗进展型脑梗死临床疗效对比[J]. 河北职工医学院学报, 2005, 22(2): 19-20
作者姓名:代瑞廷  曹艳霞  李晓芳  王淑仙  苏立凯
作者单位:河北省职工医学院附属医院,河北,保定,071000
摘    要:目的观察普通肝素钠与低分子量肝素钠治疗进展型脑梗死临床疗效及其安全性。方法将72例急性进展性脑梗死患者随机分为治疗组(36例)与对照组(36例),两组除常规治疗外,治疗组加用肝素钠50mg,2/d静脉滴注,连用5d。对照组给予低分于肝素钠5000U皮下注射,2/d,连用5d,于治疗前和治疗后14d比较两组神经功能缺缺损程度评分。结果治疗组神经功能缺损积分较对照组明显减少(P>0.05)。结论普通肝素分次静点较低分子量肝素钠治疗进展型脑梗死疗效好且相对安全。

关 键 词:低分子量肝素钠 进展性脑梗死 抗凝药物 脑卒中
文章编号:1008-6692(2005)02-0019-02
修稿时间:2005-03-01

Clinical observation on heparin and low molecular heparin in the treatment of acute progressing cerebral infarction
Dai Ruiting Cao Yanxia Li Xiaofang et al.. Clinical observation on heparin and low molecular heparin in the treatment of acute progressing cerebral infarction[J]. Journal of Hebei Medical College for Continuing Education, 2005, 22(2): 19-20
Authors:Dai Ruiting Cao Yanxia Li Xiaofang et al.
Abstract:Objective To evaluate the efficiency and safety of heparin and low molecular heparin in the treatncent of patients with acute progressing cerebral infarction. Methods 72 patients with acute progressing cerebral infarction were randomly divided into heparin and low molecular heparin group. The patients' responses to heparin and low molecular heparin were evaluated. Results In heparin the therapeutic effect was significantly higher than that of low molecular heparin group. Conclusion Heparin cerebral infarction is effective .safe and convenient in treating.
Keywords:acute progressing cerebral infarction  heparin  low molecular heparin  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号